Austin W. Boesch

Austin W. Boesch, CEO, co-inventor and co-founder of Zepteon, Inc., has 16 years of industrial R&D experience in the biopharmaceutical field. While working at Millipore he was integral to the development of a commercially available virus retention filter. While at Pfizer he performed purification process development for molecules in the clinical pipeline and commercially launched molecules. Dr. Boesch has also performed drug discovery and development at Torque Therapeutics and Tidal Therapeutics. Dr. Boesch was an Innovation fellow at the Thayer School of Engineering at Dartmouth College where he received his PhD. He has training in law, technology, entrepreneurship, financial accounting and corporate finance from the Tuck School of Business at Dartmouth College. His research at Dartmouth has included the molecular biology techniques and cellular manipulations to produce and purify recombinant human receptors. He has more than 12 publications and patents.